Veterinary Medicines

Marbodug 100 mg/ml Solution for Injection for Cattle and Pigs

Authorised
This information is not available for this product.
Download as PDF

Product identification

Medicine name:
Marbodug 100 mg/ml Solution for Injection for Cattle and Pigs
Odimar 100 mg/ml Oplossing voor injectie
Odimar 100 mg/ml Solution injectable
Odimar 100 mg/ml Injektionslösung
Active substance:
This information is not available for this product.
Target species:
  • Cattle
  • Pig
Route of administration:
  • Intramuscular use
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
This information is not available for this product.
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        3
        day
      • Meat and offal
        6
        day
      • Milk
        36
        hour
      • Milk
        72
        hour
    • Pig
      • Meat and offal
        4
        day
  • Intravenous use
    • Cattle
      • Meat and offal
        6
        day
      • Milk
        36
        hour
  • Subcutaneous use
    • Cattle
      • Meat and offal
        6
        day
      • Milk
        36
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA93
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • Packaged in Amber type II glass vial of 10ml.Vial is closed with a fluorinated bromobutyl rubber stopper oversealed with an aluminium cap. Each vial is packaged in a cardboard box.
  • Packaged in Amber type II glass vial of 20ml.Vial is closed with a fluorinated bromobutyl rubber stopper oversealed with an aluminium cap. Each vial is packaged in a cardboard box.
  • Packaged in Amber type II glass vial of 50ml.Vial is closed with a fluorinated bromobutyl rubber stopper oversealed with an aluminium cap. Each vial is packaged in a cardboard box.
  • Packaged in Amber type II glass vial of 100ml.Vial is closed with a fluorinated bromobutyl rubber stopper oversealed with an aluminium cap. Each vial is packaged in a cardboard box.
  • Packaged in Amber type II glass vial of 250ml.Vial is closed with a fluorinated bromobutyl rubber stopper oversealed with an aluminium cap. Each vial is packaged in a cardboard box.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Emdoka
Marketing authorisation date:
Manufacturing sites for batch release:
  • Produlab Pharma B.V.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V434752
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0457/002
Concerned member states:
  • Austria
  • Belgium
  • Germany
  • Luxembourg
  • Netherlands
  • Portugal
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 11/02/2022
Download
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download
German (PDF)
Published on: 22/03/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."